Literature DB >> 21647206

Characterization of episodes of irritable bowel syndrome using ecological momentary assessment.

Stephan R Weinland1, Carolyn B Morris, Yuming Hu, Jane Leserman, Shrikant I Bangdiwala, Douglas A Drossman.   

Abstract

OBJECTIVES: Patients with irritable bowel syndrome (IBS) report that symptoms occur as episodes. The nature and frequency of episodes have not been well studied.
METHODS: Using modified ecological momentary assessment (EMA), we examined clinical factors attributed to IBS symptom episodes and compared them with nonsymptom episode periods in patients with IBS-D (N=21), IBS-C (N=18), or IBS-M (N=19), and healthy controls (N=19). Symptoms were rated over 14 days on a visual ordinal scale (VOS: 0-10) randomly in morning, midday, and evening, and at wake up, bedtime, prebowel movement, and postbowel movement. Scores were evaluated for total group and across subgroups and between EMA and daily diary cards on the same day.
RESULTS: Subjects (n=57/59) reported symptom episodes 34% of the time. Episodes showed significantly higher pain levels (3.6 vs. 1.64, P<0.0001), bloating (4.57 vs. 3.02, P<0.0001), stress (3.54 vs. 2.59, P<0.0001), and decreased well-being (5.29 vs. 6.16, P<0.0001). Episode frequency/2 weeks was greatest for IBS-D (10.7±7.05) than IBS-C (8.4±5.76) and IBS-M (7.1±4.45) (P=nonsignificant). IBS-D also had shorter episodes (9 h 23 min) compared with IBS-M (15 h 01 min) and IBS-C (15 h 25 min) (P<0.04). Stool frequency and looser consistency were greater with IBS-D and similar between IBS-C and IBS-M. Abdominal pain was the greatest predictor of episode status. Diary card ratings of pain and stool frequency overestimate levels reported by EMA.
CONCLUSIONS: Episodes of IBS are associated with greater pain (strongest relationship), bloating, and stress scores, and poorer global well-being. Compared with IBS-D, IBS-C and IBS-M are similar in clinical features. Patients overreport pain and stool frequency by diary compared with EMA.

Entities:  

Mesh:

Year:  2011        PMID: 21647206     DOI: 10.1038/ajg.2011.170

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  17 in total

1.  Characterization of symptoms in irritable bowel syndrome with mixed bowel habit pattern.

Authors:  A M Su; W Shih; A P Presson; L Chang
Journal:  Neurogastroenterol Motil       Date:  2013-08-29       Impact factor: 3.598

2.  Predictors of abdominal pain in depressed pediatric inflammatory bowel disease patients.

Authors:  Arvind I Srinath; Alka Goyal; Lori A Zimmerman; Melissa C Newara; Margaret A Kirshner; Francis Nicole McCarthy; David Keljo; David Binion; Athos Bousvaros; David R DeMaso; Ada Youk; Eva M Szigethy
Journal:  Inflamm Bowel Dis       Date:  2014-08       Impact factor: 5.325

3.  The accuracy of patient-reported measures for GI symptoms: a comparison of real time and retrospective reports.

Authors:  J M Lackner; J Jaccard; L Keefer; R Firth; A M Carosella; M Sitrin; D Brenner
Journal:  Neurogastroenterol Motil       Date:  2014-12       Impact factor: 3.598

4.  Agreement between prospective diary data and retrospective questionnaire report of abdominal pain and stooling symptoms in children with irritable bowel syndrome.

Authors:  M M Self; A E Williams; D I Czyzewski; E M Weidler; R J Shulman
Journal:  Neurogastroenterol Motil       Date:  2015-05-28       Impact factor: 3.598

5.  Associations among gut permeability, inflammatory markers, and symptoms in patients with irritable bowel syndrome.

Authors:  Robert J Shulman; Monica E Jarrett; Kevin C Cain; Elizabeth K Broussard; Margaret M Heitkemper
Journal:  J Gastroenterol       Date:  2014-01-17       Impact factor: 7.527

6.  Ecological Momentary Assessment Methodology in Chronic Pain Research: A Systematic Review.

Authors:  Marcella May; Doerte U Junghaenel; Masakatsu Ono; Arthur A Stone; Stefan Schneider
Journal:  J Pain       Date:  2018-01-31       Impact factor: 5.820

7.  Real-time daily assessment of work interference on healthcare professionals' restroom use: A pilot study.

Authors:  Siobhan Hartigan; Michael Finn; Roger Dmochowski; W Stuart Reynolds
Journal:  Neurourol Urodyn       Date:  2021-02       Impact factor: 2.696

8.  The Experience Sampling Method-Evaluation of treatment effect of escitalopram in IBS with comorbid panic disorder.

Authors:  Lisa Vork; Zlatan Mujagic; Marjan Drukker; Daniel Keszthelyi; José M Conchillo; Martine A M Hesselink; Jim van Os; Ad A M Masclee; Carsten Leue; Joanna W Kruimel
Journal:  Neurogastroenterol Motil       Date:  2018-11-20       Impact factor: 3.598

9.  Association Between SLC6A4 Serotonin Transporter Gene Lainked Polymorphic Region and ADRA2A -1291C>G and Irritable Bowel Syndrome in Korea.

Authors:  Yoon Jin Choi; Sung Wook Hwang; Nayoung Kim; Ji Hyun Park; Jane C Oh; Dong Ho Lee
Journal:  J Neurogastroenterol Motil       Date:  2014-07-31       Impact factor: 4.924

10.  Patient-Specific Stress-Abdominal Pain Interaction in Irritable Bowel Syndrome: An Exploratory Experience Sampling Method Study.

Authors:  Lisa Vork; Daniel Keszthelyi; Sander M J van Kuijk; Emilio G Quetglas; Hans Törnblom; Magnus Simrén; Qasim Aziz; Maura Corsetti; Jan Tack; Zlatan Mujagic; Carsten Leue; Joanna W Kruimel; Ad A M Masclee
Journal:  Clin Transl Gastroenterol       Date:  2020-07       Impact factor: 4.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.